View Author
scopus: 24517607000

Cazenave, J.P.

( J.P. Cazenave)


platelet transfusion patient reference count platelet transfusion study group treatment platelet support increment platelet transfusions period blood cycle support event number posttransfusion component platelet dose 24- difference sample platelet components cycle 1 treatment groups 109/ system organ class product buffy analysis regression analysis buffy coats hemorrhagic count increment center effect inactivation reference platelet transfusions antibody plasma reference patients table platelet doses efficacy score regression reference platelet pools on-protocol transfusions response system 5 days method reference platelet products assay population duration 8 transfusions interval class hemostatic study center test group test pools thrombocytopenia on-protocol thrombocytopenic patients baxter healthcare corporation single-donor posttransfusion platelet counts leukocyte process covariate platelet additive solution pathogen 56- randomized 1- hour cci blood cell units




1 Most Recent Publications

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial (Article)
Rhenen, D.J. van Marblie, S. Corash, L. Flament, J. Ljungman, P. Kluter, H. Vermeij, H. Mayaudon, V. Lin, L. Kappers-Klunne, M.C. Buchholz, D. Greef, G.E. de Laforet, M. Davis, K. Conlan, M. Lioure, B. Gulliksson, H. Cazenave, J.P. Metzel, P. Pamphilon, D.
2003-03-15